Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Mutations: Results From the IFCT-1703 R2D2 Trial.

Details

Language :

English

ISSN :

0732183X

Volume :

40

Issue :

7

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

155790105

Full Text :

https://doi.org/10.1200/JCO.21.01455